Is the Amigo share price a stock market crash bargain worth buying now?

The Amigo share price is facing some strong headwinds, but the company has a plan to turn things around over the next few months.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Amigo (LSE: AMGO) share price has plunged in value this year. The stock started 2020 changing hands at around 70p. However, following the coronavirus crisis, a management spat, and rising losses, shares in the business are now dealing at 13p.

Following this decline, the stock looks cheap compared to history. But that doesn’t necessarily mean the Amigo share price is a stock market crash bargain worth buying today. There are several other factors investors need to consider before buying into this moneylender.

Amigo share price problems

Amigo only became a public business two years ago. Unfortunately, since its IPO in June 2018, the company has lurched from disaster to disaster.

This year has been particularly painful for the company and the Amigo share price. In March, its founder, James Benamor, who owned nearly two-thirds of the business, called for the company to immediately cease lending operations and challenge regulators’ claims against the business. The Financial Ombudsman Service and Financial Conduct Authority have both been placing pressure on the corporation to pay compensation to borrowers who have complained about Amigo’s lending practices.

When the company ignored its founder’s request, Benamor tried to seize control of the business with a shareholder vote in June. This attempt failed. The Amigo share price fell further when the founder then announced that he’d be selling his entire 60%-plus shareholding.

A week later, the company published more bad news. It announced that it was suspending the publication of its full-year results and setting aside more cash to deal with a substantial increase in the number of customer complaints.

New blood

Amigo has now brought former CEO Glen Crawford back to try and turn its fortunes around. The CEO stepped down last year for health reasons. He helped take the business public in 2018.

However, only time will tell if Crawford will be able to turn things around. The lender has some severe issues. If customer complaints continue to rise, there’s a genuine chance the business could become insolvent. That would be bad news for the Amigo share price.

On the other hand, if the new management can bring compensation claims under control, Amigo might be able to return to growth.

Over the past few years, many of the organisation’s peers in the high-interest loan market have collapsed, which gives the company plenty of scope to take market share. At the same time, many people are facing financial difficulty in the coronavirus crisis, and Amigo could provide some help.

Therefore, the outlook for the Amigo share price is mixed. If the company can capitalise on the current environment and get rising claims under control, it may be able to return to growth. If not, the business may not last for much longer.

As such, it may be sensible to own the stock as part of a well-diversified portfolio.

Rupert Hargreaves does not own any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »